Skip to main content
Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd — Investor Relations & Filings

Ticker · TLSA ISIN · BMG889121031 LEI · 984500769407C5E46F42 US Professional, scientific and technical activities
Open in API
Filings indexed 460 across all filing types
Latest filing 2020-02-03 Regulatory Filings
Country BM Bermuda
Listing US TLSA

About Tiziana Life Sciences Ltd

https://www.tizianalifesciences.com/

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company focused on developing innovative immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's core strategy involves utilizing alternative drug delivery routes, such as intranasal administration, to modulate the immune system. Its lead clinical candidate, foralumab (TZLS-401), is the only fully human anti-CD3 monoclonal antibody being investigated for neurological conditions. Foralumab is in clinical development for the treatment of Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS), Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), and Multiple System Atrophy (MSA). The company's pipeline also includes an anti-IL-6 receptor monoclonal antibody (TZLS-501) for potential application in lung diseases.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references a Regulatory News Service (RNS) announcement issued in the UK regarding a Notice of General Meeting. The document itself is short (2902 characters) and primarily serves to furnish the RNS announcement as an exhibit. It explicitly states that the information is being furnished and not filed, and it does not contain substantive financial data or detailed report content. According to the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2020-02-03 English
AMENDMENT NO.1 TO REGISTRATION STATEMENT
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 1 to a Form F-3 Registration Statement filed with the SEC, which is a type of registration statement used for securities offerings under the Securities Act of 1933. It includes detailed information about the securities to be offered, the offering process, risk factors, and other disclosures typical of a prospectus related to capital raising. This is not a financial report, earnings release, or management discussion, but rather a regulatory filing related to capital markets activity. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is the actual filing, not just an announcement of a filing, so it is not RPA or RNS. Hence, the classification is CAP with high confidence.
2020-01-30 English
Regulatory Filings 2020
Regulatory Filings Classification · 60% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. Without any discernible information or context, it is impossible to classify this document as any specific filing type. According to the fallback rule, when a document does not fit any specific category due to lack of information, it should be classified as a Regulatory Filing (RNS). The document length is 15,000 characters, which is substantial, but the content is not interpretable. Therefore, the best classification is RNS with moderate confidence due to the lack of readable content.
2020-01-28 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 100% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references an attached Regulatory News Service (RNS) announcement dated January 23, 2020, about the filing of an F-3. The document itself is short (2890 characters) and primarily serves to furnish the RNS announcement rather than containing substantive financial data or detailed report content. It explicitly states that the information is being furnished and not filed for certain regulatory purposes. This aligns with the characteristics of a Regulatory Filings (RNS) document, which includes miscellaneous regulatory announcements and filings that do not fit other categories. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-01-23 English
REGISTRATION STATEMENT
Capital/Financing Update Classification · 95% confidence The document is a Form F-3 Registration Statement filed with the U.S. Securities and Exchange Commission (SEC) under the Securities Act of 1933. It is a registration statement for the offering of securities, including ordinary shares, warrants, and units, with a maximum aggregate offering price of $75,000,000. The document includes details about the securities being registered, the registration fee, and the prospectus summary. It is not a financial report, earnings release, or management discussion, but rather a regulatory filing related to capital raising and securities registration. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed registration information, not just an announcement or a brief notice, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS) fallback. Hence, the classification is CAP with high confidence.
2020-01-22 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains a regulatory news service announcement about the appointment of a new board member, Mr. Gregor MacRae. The document is short (2943 characters) and primarily serves to furnish an announcement rather than provide detailed financial data or a full report. It does not contain financial statements or substantive financial analysis. The content focuses on management/board changes, but since it is a Form 6-K filing with an attached RNS announcement, it fits best under Regulatory Filings (RNS) as a general regulatory announcement rather than a full Board/Management Information filing. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-01-21 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.